Effect of Zoledronic Acid on Prevention of Bone Loss in Acute Phase First-ever Stroke Patients

NCT04652128 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Stroke

Interventions

DRUG: Zoledronic acid
DRUG: Placebo

Sponsor

Yonsei University